These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7047169)

  • 1. Influence of sulfonylureas on the secretion, disposal and effect of insulin.
    Almér LO; Johansson E; Melander A; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1982; 22(1):27-32. PubMed ID: 7047169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sulfonylurea on the secretion and disposition of insulin and C-peptide.
    Almér LO; Johansson E; Melander A; Wåhlin-Boll E
    Acta Med Scand Suppl; 1981; 656():11-8. PubMed ID: 7046346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired effect of sulfonylurea following increased dosage.
    Wåhlin-Boll E; Sartor G; Melander A; Scherstén B
    Eur J Clin Pharmacol; 1982; 22(1):21-5. PubMed ID: 7047168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects.
    Wåhlin-Boll E; Melander A; Sartor G; Scherstén B
    Eur J Clin Pharmacol; 1980 Oct; 18(3):279-83. PubMed ID: 7002565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic equivalence of once- and thrice-daily glipizide.
    Wåhlin-Boll E; Groop L; Karhumaa S; Groop PH; Tötterman KJ; Melander A
    Eur J Clin Pharmacol; 1986; 31(1):95-9. PubMed ID: 3536529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of glipizide on various consecutive insulin secretory stimulations in patients with type 2 diabetes.
    Ahrén B; Lundquist I; Scherstén B
    Diabetes Res; 1986 Jul; 3(6):293-300. PubMed ID: 3530592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD
    Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glipizide increases plasma insulin but not C-peptide level after a standardized breakfast in type 2 diabetic patients.
    Scheen AJ; Lefebvre PJ; Luyckx AS
    Eur J Clin Pharmacol; 1984; 26(4):471-4. PubMed ID: 6376145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sulfonylurea on glucose, insulin and C-peptide responses to a meal stimulus in a patient with type 2 diabetes and liver disease.
    Ahrén B; Scherstén B
    Acta Med Scand; 1984; 215(5):487-91. PubMed ID: 6430037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative single-dose kinetics and effects of four sulfonylureas in healthy volunteers.
    Sartor G; Melander A; Scherstén B; Wåhlin-Boll E
    Acta Med Scand; 1980; 208(4):301-7. PubMed ID: 6778079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glyburide and glipizide in treatment of diabetic patients with secondary failures to tolazamide or chlorpropamide.
    Lev JD; Zeidler A; Kumar D
    Diabetes Care; 1987; 10(6):679-82. PubMed ID: 3123183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glipizide on insulin secretion and insulin metabolism in obese type II diabetic patients.
    Bonora E; Pisani F; Micciolo R; Corgnati A; Muggeo M
    Diabetes Care; 1987; 10(6):687-91. PubMed ID: 3322723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrapancreatic effects of a sulphonylurea. Decrease in xylose absorption by glipizide in type II diabetics.
    Kollind M; Adamson U; Lins PE; Ohlsén P
    Acta Med Scand; 1984; 215(5):443-5. PubMed ID: 6377829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glipizide pharmacokinetics and response in diabetics.
    Huupponen R; Seppälä P; Iisalo E
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):417-22. PubMed ID: 6754633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics-effect relations of glipizide and other sulfonylureas.
    Sartor G; Melander A; Scherstén B; Wåhlin-Boll E
    Acta Endocrinol Suppl (Copenh); 1980; 239():3-5. PubMed ID: 6776762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood glucose and serum C-peptide after a single chlorpropamide dose.
    Huupponen R
    Res Commun Chem Pathol Pharmacol; 1984 Feb; 43(2):347-50. PubMed ID: 6369456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of glipizide.
    Melander A; Wåhlin-Boll E
    Am J Med; 1983 Nov; 75(5B):41-5. PubMed ID: 6424440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of glipizide after once-daily and divided doses.
    Kradjan WA; Takeuchi KY; Opheim KE; Wood FC
    Pharmacotherapy; 1995; 15(4):465-71. PubMed ID: 7479199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective potentiation of insulin-mediated glucose disposal in normal dogs by the sulfonylurea glipizide.
    Putnam WS; Andersen DK; Jones RS; Lebovitz HE
    J Clin Invest; 1981 Apr; 67(4):1016-23. PubMed ID: 7009650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.
    Groop L; Wåhlin-Boll E; Groop PH; Tötterman KJ; Melander A; Tolppanen EM; Fyhrqvist F
    Eur J Clin Pharmacol; 1985; 28(6):697-704. PubMed ID: 3933984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.